Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer

被引：0
|
作者：
Poulie, Christian [1 ]
El Fakiri, Mohamed [2 ]
Ayada, Nawal [2 ]
Gamzov, Teodor [1 ]
Muller, Marius [1 ]
Jensen, Holger [3 ]
Lindegren, Sture [4 ]
Jensen, Andreas [1 ,5 ]
Kjaer, Andreas
Eder, Ann-Christin [2 ]
Eder, Matthias [6 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Tech Univ Denmark, Lyngby, Denmark
[6] Univ Med Ctr, Freiburg, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-017
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [21] PSMA-based alpha therapy in prostate cancer
    Mike Sathekge
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3506 - 3508
  • [22] PSMA-based alpha therapy in prostate cancer
    Sathekge, Mike
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3506 - 3508
  • [23] Preliminary Evaluation of Astatine-211-Labeled Bombesin Derivatives for Targeted Alpha Therapy
    Aoki, Miho
    Zhao, Songji
    Takahashi, Kazuhiro
    Washiyama, Kohshin
    Ukon, Naoyuki
    Tan, Chengbo
    Shimoyama, Saki
    Nishijima, Ken-ichi
    Ogawa, Kazuma
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (06) : 538 - 545
  • [24] Prostate Cancer Theranostics PSMA Targeted Therapy
    Seifert, Robert
    Alberts, Ian L.
    Afshar-Oromieh, Ali
    Rahbar, Kambiz
    PET CLINICS, 2021, 16 (03) : 391 - 396
  • [25] PSMA-Targeted Therapy in Prostate Cancer
    Tagawa, Scott T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02)
  • [26] Targeted Therapy in Prostate Cancer: Beyond PSMA
    Morris, Michael J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (09) : 423 - 425
  • [27] Targeted-Alpha-Therapy With Astatine-211-Meta-Astatobenzylguanidine (211At-MABG) in the Treatment of Pheochromocytoma
    Makvandi, Mehran
    LeGeyt, Ben
    Mikitsh, John L.
    Hou, Catherine
    Pryma, Daniel A.
    PANCREAS, 2015, 44 (02) : 348 - 349
  • [28] Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer
    Watabe, Tadashi
    Kaneda-Nakashima, Kazuko
    Kadonaga, Yuichiro
    Ooe, Kazuhiro
    Sampunta, Thosapol
    Hirose, Naoki
    Yin, Xiaojie
    Haba, Hiromitsu
    Kon, Yukiyoshi
    Toyoshima, Atsushi
    Cardinale, Jens
    Giesel, Frederik L.
    Fukase, Koichi
    Tomiyama, Noriyuki
    Shirakami, Yoshifumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [29] Targeted alpha therapy using [211At]PSMA5 against refractory prostate cancer: preclinical studies for the clinical trial
    Watabe, Tadashi
    Kaneda, Kazuko
    Toyoshima, Atsushi
    Fukase, Koichi
    CANCER SCIENCE, 2024, 115 : 1561 - 1561
  • [30] Astatine-211 labelled a small molecule peptide: specific cell killing in vitro and targeted therapy in a nude-mouse model
    Liu, Weihao
    Tang, Yu
    Ma, Huan
    Li, Feize
    Hu, Yingjiang
    Yang, Yuanyou
    Yang, Jijun
    Liao, Jiali
    Liu, Ning
    RADIOCHIMICA ACTA, 2021, 109 (02) : 119 - 126
12345